Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03950791 · ClinicalTrials.gov registry record · NA
Single Session Class to Reduce Opioid Use in Chronic Pain
A NA study of Chronic Pain, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 213
- Enrollment target
- 1
- Study location
NCT03950791: Completed NA study of Chronic Pain, sponsored by Stanford University.
NCT03950791 is a NA study of Chronic Pain that has completed, run by Stanford University. The registered enrollment target is 213 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03950791, a NA study of Chronic Pain, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
- 1
- Study location
Study Summary
Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.
Primary Outcome
Clinically minimal reduction is defined as \>15% reduction in opioid use (MEDD, which is the recommended unit of measurement in studies of opioid use)
Conditions Studied
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Pain Catastrophizing Class
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
What the finished NCT03950791 record still lists
NCT03950791 is an interventional study that assigns participants to a tested intervention. The registered 213 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Health Education is the first listed.
NCT03950791 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03950791 about?
NCT03950791 is a clinical study titled "Single Session Class to Reduce Opioid Use in Chronic Pain". Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chr...
What is the current status of trial NCT03950791?
This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2019-09-23. Estimated completion is 2024-05-31.
What conditions does trial NCT03950791 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT03950791?
The interventions under investigation include: Health Education (BEHAVIORAL), Pain Catastrophizing Class (BEHAVIORAL).
Who is sponsoring clinical trial NCT03950791?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03950791 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03950791's enrollment target sits among peer trials
213 78th of 301 higher than 224 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06476886 · 213 participants · NA
Intensive Crisis Intervention
- NCT06544655 · 213 participants · Phase 1
A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
- NCT07186816 · 213 participants · NA
SUpport From PEeRs to Expand Access Study - Community
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI